Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Vaccines”

2,694 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,694 results

Early research (Phase 1)Study completedNCT00118924
What this trial is testing

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Who this might be right for
Tick-Borne Encephalitis
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Active Not RecruitingNCT05314023
What this trial is testing

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Who this might be right for
Genital Warts
Merck Sharp & Dohme LLC 1,590
Early research (Phase 1)Study completedNCT05148962
What this trial is testing

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

Who this might be right for
COVID-19
Gritstone bio, Inc. 45
Large-scale testing (Phase 3)UnknownNCT06068569
What this trial is testing

Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Testing effectiveness (Phase 2)UnknownNCT05124483
What this trial is testing

Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)

Who this might be right for
COVID-19
University Medical Center Groningen 600
Early research (Phase 1)Study completedNCT00428337
What this trial is testing

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT00779766
What this trial is testing

Efficacy, Immunogenicity and Safety of GSK Biologicals' HPV GSK 580299 Vaccine in Healthy Chinese Female Subjects

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 6,081
Large-scale testing (Phase 3)Study completedNCT01353703
What this trial is testing

Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine

Who this might be right for
PoliomyelitisTetanusAcellular Pertussis+4 more
GlaxoSmithKline 224
Large-scale testing (Phase 3)Study completedNCT05047770
What this trial is testing

A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine

Who this might be right for
Herpes Zoster
GlaxoSmithKline 2,013
Not applicableStudy completedNCT06119854
What this trial is testing

Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

Who this might be right for
MisinformationVaccine HesitancyAnxiety+2 more
City University of New York, School of Public Health 1,419
Large-scale testing (Phase 3)Study completedNCT01014845
What this trial is testing

Clinical Trial of Recombinant Hepatitis E Vaccine

Who this might be right for
Hepatitis E
Xiamen University 112,604
Testing effectiveness (Phase 2)Study completedNCT00511095
What this trial is testing

Open-Label Study of the Safety and Immunogenicity of HEPLISAV™ Hepatitis B Virus Vaccine

Who this might be right for
Hepatitis B
Dynavax Technologies Corporation 207
Post-approval studies (Phase 4)UnknownNCT00216229
What this trial is testing

Twinrix Alternative Schedule Study

Who this might be right for
Antibody Response After Vaccination
IDEWE Occupational Health Services 400
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Early research (Phase 1)WithdrawnNCT05609045
What this trial is testing

A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

Who this might be right for
COVID-19 Pandemic
Wuhan Rhegen Biotechnology Co., Ltd.
Large-scale testing (Phase 3)Study completedNCT04652102
What this trial is testing

A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

Who this might be right for
Covid19SARS-CoV-2
CureVac 39,680
Large-scale testing (Phase 3)Study completedNCT02003703
What this trial is testing

Comparative Efficacy of an Intensified Re-vaccination Scheme for Hepatitis B Virus Infection Among Patients Infected With HIV .

Who this might be right for
Hepatitis BHIV
Universidad de Valparaiso 107
Post-approval studies (Phase 4)UnknownNCT04270773
What this trial is testing

Immunogenicity and Safety of a 9-valent Human Papillomavirus Vaccine in HIV-positive Women

Who this might be right for
HIV InfectionsHPV Infection
University Hospital Virgen de las Nieves 158
Large-scale testing (Phase 3)WithdrawnNCT04990466
What this trial is testing

Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.

Who this might be right for
COVID-19
NeuroRx, Inc.
Next Page